The margin over Merck was only $170 million, but the growth gap was far wider: Lilly expanded at 44.7% while Merck managed 1.3%
Key Takeaways at a Glance Bottom line: Most GLP-1 fatigue is practical, not mysterious: appetite drops, intake shrinks, fluids/electrolytes slip, and GI side effects disrupt routines
With insurance but no savings card: Out-of-pocket costs often fall between $60 and $150 per month, depending on drug tier placement, deductibles, and coinsurance
As a result, the mechanisms underlying the impact of glucagon-like peptide-1 medications on the kidneys are unknown
Our formulas come in single-serve pouches, stick and dose packaging, as well as bottles and blister packs, providing added convenience and the highest level of confidence in the integrity of our formulas
GLP-1 drugs such as Ozempic, Trulicity, and Mounjaro all lower blood sugar, but they differ in FDA indication, average weight-loss, dosing schedule, and out-of-pocket cost